Cargando…

Correction to “New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance”

Detalles Bibliográficos
Autores principales:	Kalathil, Akil A., Guin, Subham, Ashokan, Akash, Basu, Uttara, Surnar, Bapurao, Delma, Katiana S., Lima, Leonor M., Kryvenko, Oleksandr N., Dhar, Shanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450869/ https://www.ncbi.nlm.nih.gov/pubmed/37637725 http://dx.doi.org/10.1021/acscentsci.3c00920

Ejemplares similares

New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance
por: Kalathil, Akil A., et al.
Publicado: (2023)

Clinically Approved Antiviral Drug in an Orally Administrable Nanoparticle for COVID-19
por: Surnar, Bapurao, et al.
Publicado: (2020)

Targeted Mitochondrial COQ(10) Delivery Attenuates Antiretroviral-Drug-Induced Senescence of Neural Progenitor Cells
por: Velichkovska, Martina, et al.
Publicado: (2018)

Transformation of Amphiphilic Antiviral Drugs into New Dimensional Nanovesicles Structures
por: Hamdan, Suzana, et al.
Publicado: (2022)

Histopathology and Ultrastructural Findings of Fatal COVID-19 Infections on Testis
por: Achua, Justin K., et al.
Publicado: (2021)

Antibacterial Prodrugs to Overcome Bacterial Resistance
por: Jubeh, Buthaina, et al.
Publicado: (2020)

Facile Synthesis of a Pt(IV) Prodrug of Cisplatin and Its Intrinsically (195m)Pt Labeled Analog: A Step Closer to Cancer Theranostic
por: Sharma, K. Shitaljit, et al.
Publicado: (2021)

Cisplatin for cancer therapy and overcoming chemoresistance
por: Ranasinghe, Ranmali, et al.
Publicado: (2022)

Cephalosporin Prodrug Inhibitors Overcome Metallo‐β‐Lactamase Driven Antibiotic Resistance
por: van Haren, Matthijs J., et al.
Publicado: (2021)

A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance
por: Fronik, Philipp, et al.
Publicado: (2022)

Combination therapy to overcome ferroptosis resistance by biomimetic self-assembly nano-prodrug
por: Huang, Yong, et al.
Publicado: (2023)

Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo
por: Yang, Lu, et al.
Publicado: (2021)

NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance
por: Li, Xiaoguang, et al.
Publicado: (2019)

Overcoming intrinsic spin resonances with an RF dipole
por: Bai, M, et al.
Publicado: (1998)

Cisplatin Prodrug-Conjugated Gold Nanocluster for Fluorescence Imaging and Targeted Therapy of the Breast Cancer
por: Zhou, Fangyuan, et al.
Publicado: (2016)

Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
por: Schweer, David, et al.
Publicado: (2021)

Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
por: Shi, Zhen-duo, et al.
Publicado: (2022)

Overcoming weak intrinsic depolarizing resonances with energy-jump
por: Huang, H, et al.
Publicado: (1999)

Controlled sequential in situ self-assembly and disassembly of a fluorogenic cisplatin prodrug for cancer theranostics
por: Wen, Xidan, et al.
Publicado: (2023)

Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
por: Wu, Chunjing, et al.
Publicado: (2005)

Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells
por: Schmidtova, Silvia, et al.
Publicado: (2019)

Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer
por: Huang, Linjuan, et al.
Publicado: (2023)

Nanoparticle-Mediated Delivery of Satraplatin to Overcome Cisplatin Drug Resistance
por: Jiang, Xiaohan, et al.
Publicado: (2023)

Tetrazine-mediated bioorthogonal prodrug–prodrug activation
por: Neumann, Kevin, et al.
Publicado: (2018)

Prodrugs and prodrug-activated systems in gene therapy
por: Sheikh, Semira, et al.
Publicado: (2021)

Combinatorial nanococktails via self-assembling lipid prodrugs for synergistically overcoming drug resistance and effective cancer therapy
por: Li, Tongyu, et al.
Publicado: (2022)

Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine
por: Hong, Yuan, et al.
Publicado: (2020)

Dual-Drug Nanosystem: Etoposide Prodrug and Cisplatin Coloaded Nanostructured Lipid Carriers for Lung Cancer Therapy
por: Du, Min, et al.
Publicado: (2022)

Robotic-assisted laparoscopic vesiculectomy in a patient with atypical Zinner syndrome presenting with large cyst involving bilateral seminal vesicles and vasa deferentia
por: Razdan, Shirin, et al.
Publicado: (2018)

PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells
por: Ho, Winson S., et al.
Publicado: (2016)

APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
por: Mohell, N, et al.
Publicado: (2015)

DNA damage is overcome by TRIP13 overexpression during cisplatin nephrotoxicity
por: Hama, Taketsugu, et al.
Publicado: (2021)

Natural products as a means of overcoming cisplatin chemoresistance in bladder cancer
por: Rajendran, Ganeshkumar, et al.
Publicado: (2021)

Health Benefits of Modificated Multiplatinum Derivatives as Strategies for Overcoming the Cisplatin Resistance
por: Ivanova, Stefka Achkova, et al.
Publicado: (2023)

Regulation of glucose and glutamine metabolism to overcome cisplatin resistance in intrahepatic cholangiocarcinoma
por: Yang, So Mi, et al.
Publicado: (2023)

Adjudin-loaded redox-sensitive paclitaxel-prodrug micelles for overcoming multidrug resistance with efficient targeted Colon cancer therapy
por: Chen, Deli, et al.
Publicado: (2020)

Outer Membrane Disruption Overcomes Intrinsic, Acquired, and Spontaneous Antibiotic Resistance
por: MacNair, Craig R., et al.
Publicado: (2020)

Prodrugs for Amines
por: Simplício, Ana L., et al.
Publicado: (2008)

Antiparkinson Prodrugs
por: Di Stefano, Antonio, et al.
Publicado: (2008)

Dendrimer Prodrugs
por: da Silva Santos, Soraya, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_glf2casdq7n892sqbdhmvggggv